Clinical study of mogadon. A new anticonvulsant.
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000633:toxicity; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000188:drug therapy*; D004832:Epilepsy, Absence / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage* / Q000633:toxicity; D007223:Infant; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy; D009207:Myoclonus / Q000188:drug therapy
D000927:Anticonvulsants; D006993:Hypnotics and Sedatives